Löfgren syndrome: an acute presentation within the sarcoidosis spectrum

Adam J. Brown, MD

Löfgren syndrome is the acute “black sheep” of the sarcoidosis family. Unlike the subtle onset and gradual progression of other forms, it often presents abruptly. It is usually recognised by a characteristic triad—erythema nodosum, bilateral hilar lymphadenopathy and polyarthralgia—but it remains a diagnosis of exclusion and can be confused with rheumatological or infectious diseases.

In the report, Brown was introduced as the host of the Healio Rheuminations podcast and an associate physician in the Department of Rheumatic and Immunologic Diseases at Cleveland Clinic. His aim was to help clinicians understand Löfgren syndrome and other forms of sarcoidosis.

A clinical example described by rheumatologist Adam J. Brown involved a 57-year-old woman with subacute inflammatory arthritis and a mild erythematous forearm lesion. Tests for antinuclear antibodies and cyclic citrullinated peptide were negative. The diagnosis was Löfgren syndrome based on the typical triad. The syndrome is considered an acute sarcoidosis attack, but it behaves differently from many other forms because it is usually self-limited.

Brown said that, in general, the woman was doing well. He contrasted the syndrome’s often self-limiting course with the many rheumatological diseases that tend to persist, explaining why it offers an unusual management situation for rheumatologists.

Historical description
Swedish clinician Sven Halvar Löfgren first described the condition in 1946 with Holger Lundbeck, after reviewing 178 cases of erythema nodosum. In their early work, painful joints and joint swelling were frequent. Later reports helped distinguish the condition from tuberculosis and described the combination of bilateral hilar lymphadenopathy, erythema nodosum and mild inflammatory arthritis. Joint symptoms often improve within weeks or months.

In the 1946 series, 57% had painful joints and 27% had joint swelling. Brown described how tuberculosis and streptococcal disease were initially considered before sarcoidosis was recognised; most patients also had inflammatory arthritis.

According to Brown’s historical account, the 1951 report described 212 patients with bilateral hilar lymphadenopathy and negative tuberculin skin tests: 113 had erythema nodosum, 101 had joint pain and 70 had joint swelling. Löfgren noted that the joint symptoms were mild and usually subsided within weeks, and that most of the symptoms of the triad would disappear. He did not name the syndrome after himself.

Specific populations and outcomes
Löfgren syndrome has been reported particularly often in Scandinavia and Spain. A Barcelona group followed 113 patients between 1974 and 1996 for an average of 58 months and defined the syndrome as erythema nodosum, peri-articular ankle inflammation and bilateral hilar adenopathy. Most patients retained ankle movement despite the inflammation. Arthralgia in joints other than the ankles occurred in about two thirds of patients, and uveitis was seen in a small number.

Brown highlighted that the 212 historical patients came from a single hospital, suggesting a predisposition in that population. He noted that much of the later evidence came from Spain and cited a study suggesting that Löfgren syndrome accounted for almost half of sarcoidosis cases there.

The Barcelona follow-up described in the report was prospective and extended over a long patient-recruitment period. Brown emphasised peri-articular ankle inflammation: preservation of ankle movement argues against marked synovitis.

Only 6% of the Barcelona patients had a recurrence between two and twenty years. The low recurrence rate and the typical triad are important clinical clues, but every patient still needs an individual assessment. Cases vary seasonally: around 70% in the reported series occurred between March and July, suggesting that environmental factors may contribute.

Brown also reported that no patient with the characteristic triad developed an alternative diagnosis in that cohort.

This information is educational and does not replace a medical examination or medical advice.

Adapted from Rob Volansky. Source: https://www.healio.com/news/rheumatology/20200131/a-lfty-diagnosis-amid-shades-of-sarcoidosis

Rating: 0 stars, 0 votes.